Cargando…

Integrase Strand Transfer Inhibitors and Weight Gain in Children and Youth With Perinatal Human Immunodeficiency Virus in the DC Cohort

We conducted a retrospective analysis of 38 children and youth with human immunodeficiency virus (aged 0–19 years) in the United States and report an increased rate of change of BMI-for-age z score after initiating integrase strand transfer inhibitors (+0.19 z score units/year [95% confidence interv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koay, Wei Li A, Dirajlal-Fargo, Sahera, Levy, Matthew E, Kulie, Paige, Monroe, Anne, Castel, Amanda D, Rakhmanina, Natella Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291625/ https://www.ncbi.nlm.nih.gov/pubmed/34295943 http://dx.doi.org/10.1093/ofid/ofab308

Ejemplares similares

Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts
por: Monroe, Anne K, et al.
Publicado: (2021)

Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2023)

Serum Albumin Is Associated With Higher Inflammation and Carotid Atherosclerosis in Treated Human Immunodeficiency Virus Infection
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2018)

933. Serum Albumin Is Associated With Higher Inflammation and Carotid Atherosclerosis in Treated HIV Infection
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2018)

Pediatric Patients with SARS-CoV-2 Infection: Clinical Characteristics in the United States from a Large Global Health Research Network
por: Desai, Ankita, et al.
Publicado: (2020)

Vitamin K & D Deficiencies Are Independently Associated With COVID-19 Disease Severity
por: Desai, Ankita P, et al.
Publicado: (2021)

Integrating HIV Pre-Exposure Prophylaxis (PrEP) Education During Medical Residency: Training Outcomes and Suggestions for Learning Effectiveness
por: Ogundare, Matilda Olajumoke, et al.
Publicado: (2023)

Weight Gain and Lipid Profile Changes in Koreans with Human Immunodeficiency Virus undergoing Integrase Strand Transfer Inhibitor-Based Regimens
por: Kim, Jin, et al.
Publicado: (2022)

2528. Inflammation and Plasma Selenium and Chromium in Ugandan Children Living with HIV
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019)

HIV Drug Resistance in Children and Adolescents: Always a Challenge?
por: Koay, Wei Li A., et al.
Publicado: (2021)

Psychosocial impacts of the COVID-19 pandemic from a cross-sectional Survey of people living with HIV in Washington, DC
por: Monroe, Anne K., et al.
Publicado: (2023)

Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2016)

No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gain
por: Verburgh, Myrthe L., et al.
Publicado: (2023)

1275. Factors Associated with Patient-Provider Discussions about Preexposure Prophylaxis Among Young Men Who Have Sex with Men in Washington, DC
por: Ware, Chelsea, et al.
Publicado: (2019)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy
por: Goldberg, Rachel N., et al.
Publicado: (2021)

Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA
por: Rakhmanina, Natella, et al.
Publicado: (2016)

Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019)

Integrase Strand Transfer Inhibitors in HIV Therapy
por: Mesplède, Thibault, et al.
Publicado: (2013)

Resistance Mutations outside the Integrase Coding Region Have an Effect on Human Immunodeficiency Virus Replicative Fitness but Do Not Affect Its Susceptibility to Integrase Strand Transfer Inhibitors
por: Weber, Jan, et al.
Publicado: (2013)

HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases
por: Zhao, Xue Zhi, et al.
Publicado: (2016)

1043. The impact of integrase strand transfer inhibitors (InSTIs) on weight gain among adults with HIV in clinical care
por: Thatipelli, Sneha, et al.
Publicado: (2020)

1049. Weight Gain in Persons Living with HIV (PLWH) Treated with Bictegravir Compared to Other Integrase Strand Transfer Inhibitors
por: Fang, Michelle, et al.
Publicado: (2020)

1566. Determinants associated with weight gain among persons with HIV who switch to integrase strand transfer inhibitors (INSTI)
por: Cutshaw, Melissa Klein, et al.
Publicado: (2023)

Pharmacokinetic drug interactions of integrase strand transfer inhibitors
por: Lu, Chi-Hua, et al.
Publicado: (2021)

HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
por: Foster, Emma G., et al.
Publicado: (2022)

Integrase Strand Transfer Inhibitors Play the Main Role in Greater Weight Gain Among Men With Acute and Early HIV Infection
por: Wu, Kuan-Sheng, et al.
Publicado: (2020)

Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania
por: Henerico, Shimba, et al.
Publicado: (2022)

Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors
por: Malet, Isabelle, et al.
Publicado: (2017)

3′-Processing and strand transfer catalysed by retroviral integrase in crystallo
por: Hare, Stephen, et al.
Publicado: (2012)

Multiple choices for HIV therapy with integrase strand transfer inhibitors
por: Raffi, Francois, et al.
Publicado: (2012)

Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors
por: Zhao, Xue Zhi, et al.
Publicado: (2017)

HIV drug resistance against strand transfer integrase inhibitors
por: Anstett, Kaitlin, et al.
Publicado: (2017)

Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs
por: Smith, Steven J., et al.
Publicado: (2021)

Different Pathways Conferring Integrase Strand-Transfer Inhibitors Resistance
por: Richetta, Clémence, et al.
Publicado: (2022)

Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China
por: Xia, Huan, et al.
Publicado: (2023)

Acute development of Cushing syndrome in an HIV-infected child on atazanavir/ritonavir based antiretroviral therapy
por: Dubrocq, Gueorgui, et al.
Publicado: (2017)

333. Weight Gain Among HIV-Infected Patients in Southern India on Treatment with Integrase Strand Transfer Inhibitor-based Antiretroviral Therapy
por: Khan, Rifa, et al.
Publicado: (2019)

Contribution of Human Immunodeficiency Virus Type 1 Minority Variants to Reduced Drug Susceptibility in Patients on an Integrase Strand Transfer Inhibitor-Based Therapy
por: Gibson, Richard M., et al.
Publicado: (2014)

HIV care continuum outcomes among recently diagnosed people with HIV (PWH) in Washington, DC
por: Jaurretche, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k46go3u5ia0hmb1oav8ot8p283